
The company has been blamed for fuelling the opioid crisis by promoting its drug OxyContin

The company has been blamed for fuelling the opioid crisis with the promotion of its drug OxyContin

For pursuing the case, the former employee will receive about $250m

The Sackler family will pay the amount over 18 years to victims of addiction and US states

US Supreme Court rejects Merck’s appeal over patent dispute verdict of $2.54bn

Claims relate to Purdue's involvement in fuelling the opioid addiction crisis

Company maintains it has not committed any wrongdoing

Company faces new accusations of dishonest marketing tactics

Agreement reached with a plaintiff's executive committee

Indivior’s Gilles Picard charts a path to greater patient access and new therapies

A number of companies are accused of colluding on drug prices

Upcoming federal trial puts a number of companies in the spotlight